2018
DOI: 10.1007/s11914-018-0455-7
|View full text |Cite
|
Sign up to set email alerts
|

Mouse Cre Models for the Study of Bone Diseases

Abstract: Recent studies have shown that many bone cell-targeted Cre models are not as specific as originally thought. To ensure accurate data interpretation, it is important for investigators to test for unexpected recombination events due to transient expression of Cre recombinase during development or in precursor cells and to be aware of the potential for germ line recombination of targeted genes as well as the potential for unexpected phenotypes due to the Cre transgene. Although many of the bone-targeted Cre-delet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
51
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 60 publications
(57 citation statements)
references
References 84 publications
2
51
0
Order By: Relevance
“…This promoter was originally thought to be expressed in preosteocytes, osteocytes, odontoblasts and some pulp cells (Toyosawa et al, 2001; Feng et al, 2003; Kalajzic et al, 2004; Lu et al, 2007). However, subsequent studies have shown that it is expressed in some late osteoblasts as well (Kalajzic et al, 2013; Dallas et al, 2018), which may be due to the sensitivity of the tdTomato reporter in the Ai9 mouse line, even to extremely low levels of Cre recombinase (reviewed in Dallas et al, 2018). In our hands, in bone tissue, the tdTomato transgene was strongly expressed in the majority of embedded osteocytes, preosteocytes, and some late osteoblasts on the bone surface when used with the 10 kb Dmp1 Cre driver (Figure 1A) (a Cre negative littermate control is shown at right).…”
Section: Resultsmentioning
confidence: 99%
“…This promoter was originally thought to be expressed in preosteocytes, osteocytes, odontoblasts and some pulp cells (Toyosawa et al, 2001; Feng et al, 2003; Kalajzic et al, 2004; Lu et al, 2007). However, subsequent studies have shown that it is expressed in some late osteoblasts as well (Kalajzic et al, 2013; Dallas et al, 2018), which may be due to the sensitivity of the tdTomato reporter in the Ai9 mouse line, even to extremely low levels of Cre recombinase (reviewed in Dallas et al, 2018). In our hands, in bone tissue, the tdTomato transgene was strongly expressed in the majority of embedded osteocytes, preosteocytes, and some late osteoblasts on the bone surface when used with the 10 kb Dmp1 Cre driver (Figure 1A) (a Cre negative littermate control is shown at right).…”
Section: Resultsmentioning
confidence: 99%
“…Other considerations may relate to when in development insulin signaling disruption in osteoblasts occurs (prenatally vs. postnatally); at what stage of osteoblastogenesis the disruption manifests (progenitor vs mature osteoblast, etc. ); as well as possible issues with certain Cre-recombinase mouse models and the lack-of specificity for targeting only bone cells 27,28 .…”
Section: Discussionmentioning
confidence: 99%
“…For example, a recent study in which PDGFRb was deleted from Osterix-expressing cells found no notable defects in skeletal development, but severe impairment of fracture healing (8) , demonstrating contextual distinctions between development and fracture repair. Further, skeletal cell-and bone-specific gene deletion during development may alter the number, location, or niche of progenitor cells that, during injury, are activated for skeletal regeneration (9) . In this study, we assessed the effects of conditional gene deletion from osteochondroprogenitors on endochondral bone fracture repair, with deletion performed either constitutively during development or inducibly after normal development to skeletal maturity prior to fracture.…”
Section: Introductionmentioning
confidence: 99%